Chief Veterinary Officer

In the eighties, Klaus studied veterinary medicine followed by a thesis in applied biochemistry in boar reproduction at the Veterinary School in Hannover, Germany.
From 1991 to 1994 Klaus worked at Pfizer Animal Health in Germany. Since 1995, Klaus is consulting the industry regarding animal health, the development and registration of animal health products and plans, supervises and conducts safety and efficacy studies testing veterinary medicinal products in various animal species. Since 1997, as founder, he is the CEO of the contract research organisation and regulatory consultancy KLIFOVET AG, Munich, Germany, one of the leading organisations providing dedicated services to support new product development and registration for animal health products. He has extensive experience consulting all, multinationals, family businesses and start-ups how to develop animal health products and has led various organisations to successful granting of marketing authorisations for vaccines, biologicals and pharmaceuticals.

Klaus is active in various animal health and veterinary organisations including the Association of Veterinary Consultants (AVC), the European College for Veterinary Pharmacology and Toxicology, member of AAVP, AAVPT and WAAVP and selected member of organisation committees of AAVM2014-2020 and acts regularly as organiser of international conferences.
Multiple scientific publications on antiparasitics, antimicrobials, vaccines, and novel therapies in various animal species show the broad spectrum of expertise (

Other speakers

Emmanuel Hanon CEO Vicebio
Sven Arnouts Business Development Manager Ghent University - Provaxs
Lourdes Mottier Head of Business Development Strategy Elanco Animal Health
Hans Nauwynck - Panelist Professor University of Ghent
Michael Hemprich - Moderator
Stefaan Wera Chief Operating Officer/Co-founder Virovet
Joris Vandeputte - Moderator President and Founder VacciM
Lauren Carde - Moderator V.P. Operations and Regulatory Affairs Paul Dick and Associates
Vladimir Pucovsky Scientific Administrator EMA Europa
Jose Carlos Mancera - panelist Senior Clinical Manager Zoetis
Liesbeth Ceelen - Moderator CEO BioLizard
Stein Aerts - panelist Scientific Director & Group Leader VIB
Daniel Jameson - panelist CEO Biorelate
Johannes Charlier Managing Director Kreavet
Jan Wauters Science & Technology Counselor Flanders Investment & Trade
Roxane Feller Secretary General Animal Health Europe
Hans Van Der Weken Postdoctoral Researcher Ghent University
Niels Vander Elst Postdoctoral Researcher Ghent University & KULeuven
Jeroen De Buck Professor Veterinary Microbiology University of Calgary
Kathleen Marchal Professor Bioinformatics University of Ghent
Paul Hodgson Director of Operations VIDO
Nathalie Vanderheijden Coordinator fot the EUP AH&W University of Ghent
Ann Martens Dean of the Faculty of Veterinary Medicine Ghent University
Lionel Malbec Product Manager Quantoom Biosciences
Lucas Decuypere CEO Allegro
Jelena Suran CEO Apiotix Technologies
Paul Dick Founder and President Paul Dick and Associates
Laetitia Cicchelero Cross-Health platform coordinator - Provaxs University of Ghent
Hervé Poulet Director of Strategic Partnering Boehringer-Ingelheim Animal Health
Eduardo Pontes Associate Director Research Alliances (EU) - External Innovation Zoetis
Filip Goossens Senior Investment Manager PMV
Sanjay Vashee Professor and Rockville Campus Director J. Craig Venter Institute
Lucy Davidson Professor of Veterinary Clinical Genetics and MRC Clinician Scientist Fellow Royal Veterinary College
Charles Owen CEO 272BIO
Annelies Bogaerts CDO Benno Therapeutics
Andrea Mariani CEO Soundsafe Care
Thomas Demeester Assistant Professor University of Ghent
Matthias Hofer Managing Partner SC Group (Stonehaven Cozmix Group AG)
Mathieu Peyrou Global Pharmaceuticals Development Director CEVA
Steve Nanchen Head external innovation Elanco

Interested? Register now!

Register here